Advances in Intravitreal Injections

Posted by: Clemson Eye in News

By Donald Glaser, MDClemson Eye News, April  2015 There’s some good news for patients with diabetic macular edema (DME). Iluvien was recently approved by the FDA to treat DME. It’s an injectable micro-insert that provides sustained treatment for 36 months. The insert continuously delivers a sub-microgram dose of fluocinolone acetonide (FAc), a corticosteroid, for three […]

Read More